Inflammatory or malignant? The establishment of a molecular classifier to differentiate early Mycosis fungoides from benign inflammatory dermatoses.

Inflammatory or malignant? The establishment of a molecular classifier to differentiate early Mycosis fungoides from benign inflammatory dermatoses. - MF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037296

Enrollment

200

Registered

2025-07-01

Start date

2025-06-27

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C84.0

Interventions

Group 1: The study retrospectively analyzes blood and tissue samples from patients with mycosis fungoides (MF) (study group) as well as patients with eczema, psoriasis, and other benign inflammatory d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: Reason to believe that patients do not consent to the use of their biomaterials Reason to believe that the samples may be needed again for clinical care during the 10-year storage period

Design outcomes

Primary

Measure	Time frame
The area under the ROC curve (AUC) of the classifier in distinguishing MF from inflammatory skin diseases, based on independent validation.	—

Secondary

Measure	Time frame
Correlation of the molecular classifier results with histopathological findings and clinical diagnosis, including disease stage and treatment history, to assess its potential clinical utility.	—

Countries

Germany

Contacts

Public ContactNatalie Garzorz-Stark

Klinik für Dermatologie und Venerologie

natalie.garzorz-stark@uniklinik-freiburg.de0761-270-67710

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026